BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 3755750)

  • 1. Molecular determinants of alphavirus neurovirulence: nucleotide and deduced protein sequence changes during attenuation of Venezuelan equine encephalitis virus.
    Johnson BJ; Kinney RM; Kost CL; Trent DW
    J Gen Virol; 1986 Sep; 67 ( Pt 9)():1951-60. PubMed ID: 3755750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleotide sequence of the 26 S mRNA of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and deduced sequence of the encoded structural proteins.
    Kinney RM; Johnson BJ; Brown VL; Trent DW
    Virology; 1986 Jul; 152(2):400-13. PubMed ID: 3088830
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The full-length nucleotide sequences of the virulent Trinidad donkey strain of Venezuelan equine encephalitis virus and its attenuated vaccine derivative, strain TC-83.
    Kinney RM; Johnson BJ; Welch JB; Tsuchiya KR; Trent DW
    Virology; 1989 May; 170(1):19-30. PubMed ID: 2524126
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Attenuation of Venezuelan equine encephalitis virus strain TC-83 is encoded by the 5'-noncoding region and the E2 envelope glycoprotein.
    Kinney RM; Chang GJ; Tsuchiya KR; Sneider JM; Roehrig JT; Woodward TM; Trent DW
    J Virol; 1993 Mar; 67(3):1269-77. PubMed ID: 7679745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular evidence for the origin of the widespread Venezuelan equine encephalitis epizootic of 1969 to 1972.
    Kinney RM; Tsuchiya KR; Sneider JM; Trent DW
    J Gen Virol; 1992 Dec; 73 ( Pt 12)():3301-5. PubMed ID: 1469368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nucleotide sequence of the genome region encoding the 26S mRNA of eastern equine encephalomyelitis virus and the deduced amino acid sequence of the viral structural proteins.
    Chang GJ; Trent DW
    J Gen Virol; 1987 Aug; 68 ( Pt 8)():2129-42. PubMed ID: 2886548
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recombinant vaccinia/Venezuelan equine encephalitis (VEE) virus expresses VEE structural proteins.
    Kinney RM; Esposito JJ; Johnson BJ; Roehrig JT; Mathews JH; Barrett AD; Trent DW
    J Gen Virol; 1988 Dec; 69 ( Pt 12)():3005-13. PubMed ID: 2462013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A biochemical comparison of the in vitro replication of a virulent and an avirulent strain of Venezuelan encephalitis virus.
    Mecham JO; Trent DW
    J Gen Virol; 1983 May; 64(Pt 5):1111-9. PubMed ID: 6842187
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Molecular evidence that epizootic Venezuelan equine encephalitis (VEE) I-AB viruses are not evolutionary derivatives of enzootic VEE subtype I-E or II viruses.
    Sneider JM; Kinney RM; Tsuchiya KR; Trent DW
    J Gen Virol; 1993 Mar; 74 ( Pt 3)():519-23. PubMed ID: 8445371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genetic evidence that epizootic Venezuelan equine encephalitis (VEE) viruses may have evolved from enzootic VEE subtype I-D virus.
    Kinney RM; Tsuchiya KR; Sneider JM; Trent DW
    Virology; 1992 Dec; 191(2):569-80. PubMed ID: 1448915
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Specific restrictions in the progression of Venezuelan equine encephalitis virus-induced disease resulting from single amino acid changes in the glycoproteins.
    Grieder FB; Davis NL; Aronson JF; Charles PC; Sellon DC; Suzuki K; Johnston RE
    Virology; 1995 Feb; 206(2):994-1006. PubMed ID: 7856110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo.
    Pushko P; Parker M; Ludwig GV; Davis NL; Johnston RE; Smith JF
    Virology; 1997 Dec; 239(2):389-401. PubMed ID: 9434729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variants of Venezuelan equine encephalitis virus that resist neutralization define a domain of the E2 glycoprotein.
    Johnson BJ; Brubaker JR; Roehrig JT; Trent DW
    Virology; 1990 Aug; 177(2):676-83. PubMed ID: 1695412
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Attenuated mutants of Venezuelan equine encephalitis virus containing lethal mutations in the PE2 cleavage signal combined with a second-site suppressor mutation in E1.
    Davis NL; Brown KW; Greenwald GF; Zajac AJ; Zacny VL; Smith JF; Johnston RE
    Virology; 1995 Sep; 212(1):102-10. PubMed ID: 7676619
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genome sequences of a mouse-avirulent and a mouse-virulent strain of Ross River virus.
    Faragher SG; Meek AD; Rice CM; Dalgarno L
    Virology; 1988 Apr; 163(2):509-26. PubMed ID: 2833022
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The immunogenic properties of a recombinant vaccinia virus with an incorporated DNA copy of the 26S RNA of the Venezuelan equine encephalomyelitis virus].
    Sviatchenko VA; Agapov EV; Urmanov IKh; Serpinskiĭ OI; Frolov IV; Kolykhalov AA; Ryzhikov AB; Netesov SV
    Vopr Virusol; 1993; 38(5):222-6. PubMed ID: 8284922
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A single-site mutant and revertants arising in vivo define early steps in the pathogenesis of Venezuelan equine encephalitis virus.
    Aronson JF; Grieder FB; Davis NL; Charles PC; Knott T; Brown K; Johnston RE
    Virology; 2000 Apr; 270(1):111-23. PubMed ID: 10772984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycoproteins E2 of the Venezuelan and eastern equine encephalomyelitis viruses contain multiple cross-reactive epitopes.
    Pereboev AV; Razumov IA; Svyatchenko VA; Loktev VB
    Arch Virol; 1996; 141(11):2191-205. PubMed ID: 8973533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro synthesis of infectious venezuelan equine encephalitis virus RNA from a cDNA clone: analysis of a viable deletion mutant.
    Davis NL; Willis LV; Smith JF; Johnston RE
    Virology; 1989 Jul; 171(1):189-204. PubMed ID: 2525837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Neurovirulence evaluation of Venezuelan equine encephalitis (VEE) vaccine candidate V3526 in nonhuman primates.
    Fine DL; Roberts BA; Terpening SJ; Mott J; Vasconcelos D; House RV
    Vaccine; 2008 Jun; 26(27-28):3497-506. PubMed ID: 18508163
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.